Back to Authors

Paul, Stefan N.

A5104146990 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 5

Compendium of Health and Wellness Coaching: 2023 Addendum

Journal of Integrative and Complementary Medicine | March 28, 2025 | Volume: 31 | Issue: 8 | Pages: 726-736

10.1089/jicm.2024.0672 | PMID 40152886

Phenotypic Characterization of Patients with ADPKD with PKD1 and PKD2 Pathogenic Variants Using Advanced Imaging Biomarkers

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.2024jkdywd8g

Characterization of GANAB Phenotype in Patients with ADPKD Using Advanced Imaging Biomarkers

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.2024xrre28mc

Characterization of IFT140 Phenotype in Patients with ADPKD Using Advanced Imaging Biomarkers

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.20240vzj2pha

Risk factors for post-acute sequelae of COVID-19: Survey results from a tertiary care hospital

Journal of Investigative Medicine | July 24, 2023 | Volume: 71 | Issue: 8 | Pages: 896-906

10.1177/10815589231190560 | PMID 37485961

Identifying risk factors for post-acute sequelae of COVID-19 (PASC) is important. We conducted a multicenter cross-sectional survey study to define and characterize risk factors for severe COVID-19 in adults (≥18 years) treated at our virtual COVID-19 clinic from March 1, 2020, through March 31, 2021. We assessed patient demographics, symptom types, and persistence, incidence of PASC, and COVID-19–caused hospitalizations. Surveyed patients were also asked to rate their perception of the severity of their acute COVID-19 symptoms. Continuous variables were summarized descriptively. Differences among groups categorized by acute COVID-19 symptom severity level (mild/very mild, moderate, and severe/very severe) were evaluated with the Kruskal–Wallis rank sum test for continuous measures and the Pearson χ 2 test for categorical measures. A total of 3094 adults completed the survey. More respondents with severe/very severe acute COVID-19 symptoms reported having PASC than did those with mild/very mild and moderate acute symptoms. A significantly greater proportion of respondents with PASC were women (68.4% vs 56.7%, p < 0.001), had been hospitalized (12.2% vs 4.4%, p < 0.001), reported having negative psychological COVID-19–related repercussions (39.9% vs 15.3%, p < 0.001), and required more than 1 month to resume normal activities (38.8% vs 12.9%, p < 0.001) than did those without PASC. These findings may improve our understanding of PASC and provide a framework for early recognition of and intervention for patients at higher risk for PASC. Further research is needed to understand the predictors of persistent symptoms after acute SARS-CoV-2 infection and the risk of PASC.